100s of titles, one news app for just $10 a month.
Dive Deeper:
Earnings Preview For Kala Pharmaceuticals
Kala Pharmaceuticals (NASDAQ:KALA) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to…
Preview: Processa Pharmaceuticals's Earnings
Processa Pharmaceuticals (NASDAQ:PCSA) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
Salarius Pharmaceuticals's Earnings: A Preview
Salarius Pharmaceuticals (NASDAQ:SLRX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
RVL Pharmaceuticals plc - Ordinary Shares's Earnings: A Preview
RVL Pharmaceuticals plc - Ordinary Shares (NASDAQ:RVLP) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's…
One subscription that gives you access to news from hundreds of sites
Longeveron's Earnings: A Preview
Longeveron (NASDAQ:LGVN) is set to give its latest quarterly earnings report on Friday, 2022-05-13. Here's what investors need to know…
A Preview Of HyreCar's Earnings
HyreCar (NASDAQ:HYRE) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know…
Get all your news in one place
Latest Business news:
Wage growth likely way behind inflation
New figures are likely to show wages were growing at an annual rate of 2.5 per cent as of the…
Read news from The Economist, FT, Bloomberg and more, with one subscription
Learn More
Markets rally eyeing China reopening
London (AFP) - Global stock markets rallied Tuesday on hopes that China will ease its weeks-long Covid lockdown and gradually…
Netflix Lays Off 150 Staffers in Cutback After Subscriber Loss
Netflix  Inc. said Tuesday it’s laying off about 150 employees, fallout from the surprising drop in customers the streaming company…
Will social media companies crack down on the racist conspiracy theory behind the Buffalo massacre?
The Buffalo, New York, mass shooting that claimed 10 lives Saturday was an event shaped by, and for, internet platforms,…
The Indian economy is being rewired. The opportunity is immense
And so are the stakes
From analysis to good news, read the world’s best news in one place
Bucking the trend: Is there a future for ultra-long-haul flights in a net-zero carbon world?
As the world gets more serious about climate action, long-haul flights such as those introduced by Qantas will come under…
Coinbase Responds to Crypto Rout
The crypto trading platform had planned to triple its employee headcount, but suspended hiring as its stock fell sharply.

Earnings Preview For Syros Pharmaceuticals

By Benzinga Insights

Syros Pharmaceuticals (NASDAQ:SYRS) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement.

Analysts estimate that Syros Pharmaceuticals will report an earnings per share (EPS) of $-0.47.

Syros Pharmaceuticals bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company beat EPS by $0.09, which was followed by a 0.9% drop in the share price the next day.

Here's a look at Syros Pharmaceuticals's past performance and the resulting price change:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.47 -0.44 -0.37 -0.46
EPS Actual -0.38 -0.41 -0.36 -0.23
Price Change % -0.9% 3.17% -4.29% -5.97%

Stock Performance

Shares of Syros Pharmaceuticals were trading at $0.8412 as of May 12. Over the last 52-week period, shares are down 83.25%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.

To track all earnings releases for Syros Pharmaceuticals visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

What is inkl?
The world’s most important news, from 100+ trusted global sources, in one place.
Morning Edition
Your daily
news overview

Morning Edition ensures you start your day well informed.

No paywalls, no clickbait, no ads
Enjoy beautiful reading

Content is only half the story. The world's best news experience is free from distraction: ad-free, clickbait-free, and beautifully designed.

Expert Curation
The news you need to know

Stories are ranked by proprietary algorithms based on importance and curated by real news journalists to ensure that you receive the most important stories as they break.

Dive Deeper:
Earnings Preview For Kala Pharmaceuticals
Kala Pharmaceuticals (NASDAQ:KALA) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to…
Preview: Processa Pharmaceuticals's Earnings
Processa Pharmaceuticals (NASDAQ:PCSA) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
Salarius Pharmaceuticals's Earnings: A Preview
Salarius Pharmaceuticals (NASDAQ:SLRX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
RVL Pharmaceuticals plc - Ordinary Shares's Earnings: A Preview
RVL Pharmaceuticals plc - Ordinary Shares (NASDAQ:RVLP) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's…
One subscription that gives you access to news from hundreds of sites
Longeveron's Earnings: A Preview
Longeveron (NASDAQ:LGVN) is set to give its latest quarterly earnings report on Friday, 2022-05-13. Here's what investors need to know…
A Preview Of HyreCar's Earnings
HyreCar (NASDAQ:HYRE) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know…
Get all your news in one place